#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	16320	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2126	759.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1420	1420	C	910	C,A	873,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29388	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3841	763.7	0	.	n	.	0	T695C	SNP	695	695	T	1170	1170	C	890	C	847	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29388	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3841	763.7	0	.	n	.	0	G1337A	SNP	1337	1337	G	1812	1812	A	960	A,G	913,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29388	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3841	763.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2446	2446	C	935	C,T	892,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29388	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3841	763.7	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3072	3072	T	863	T	822	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29388	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3841	763.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2520	2520	A	879	A	838	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_X_01360c	folP.WHO_X_01360c	1	1	27	2216	folP	852	852	100.0	folP.l15.c17.ctg.1	1644	134.2	1	SNP	p	R228S	1	.	.	682	684	AGC	1148	1150	AGC	235;233;236	A;G;C	226;222;223	folP.WHO_X_01360c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5704	gyrA	2751	2751	100.0	gyrA.l15.c30.ctg.1	3447	164.7	1	SNP	p	S91F	0	.	.	271	273	TCC	594	596	TCC	215;213;214	T;C,T;C	204;201,1;203	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5704	gyrA	2751	2751	100.0	gyrA.l15.c30.ctg.1	3447	164.7	1	SNP	p	D95N	0	.	.	283	285	GAC	606	608	GAC	205;210;209	G;A,G;C	192;196,1;197	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5704	gyrA	2751	2751	100.0	gyrA.l15.c30.ctg.1	3447	164.7	1	SNP	p	D95G	0	.	.	283	285	GAC	606	608	GAC	205;210;209	G;A,G;C	192;196,1;197	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1716	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1338	127.5	1	SNP	p	G45D	0	.	.	133	135	GGC	488	490	GGC	198;196;196	G;G;C	189;188;187	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	882	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1173	75.1	0	.	n	.	0	A197.	DEL	197	197	A	620	620	A	200	A	192	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	5484	parC	2304	2304	99.83	parC.l6.c30.ctg.1	2894	188.1	1	SNP	p	D86N	0	.	.	256	258	GAC	539	541	GAC	228;227;231	G,A;A;C	221,1;218;220	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	5484	parC	2304	2304	99.83	parC.l6.c30.ctg.1	2894	188.1	1	SNP	p	S88P	0	.	.	262	264	TCC	545	547	TCC	228;225;226	T;C;C	217;218;217	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4498	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2760	162.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1618	1620	GGC	210;209;205	G;G;C	201;201;196	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	3972	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2491	158.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1313	1315	GCA	225;224;225	G;C;A	208;206;212	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3972	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2491	158.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1316	1318	ATC	224;221;223	A;T;C	211;207;209	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3972	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2491	158.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1328	1330	GTG	220;216;216	G;T;G	206;201;202	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3972	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2491	158.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1328	1330	GTG	220;216;216	G;T;G	206;201;202	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3972	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2491	158.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1832	1834	ACC	193;194;193	A;C;C	176;183;181	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3972	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2491	158.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1886	1888	GCG	191;194;191	G;C;G	168;163;167	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3972	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2491	158.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1886	1888	GCG	191;194;191	G;C;G	168;163;167	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3972	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2491	158.5	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2009	2011	GGC	164;162;163	G;G;C	152;151;153	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3972	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2491	158.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2018	2020	GGC	155;156;155	G;G;C	144;146;144	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3972	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2491	158.5	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2036	2038	CCG	129;129;131	C,G;C;G	104,3;105;106	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6090	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3161	191.9	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1671	1673	CCG	206;207;204	C;C,T;G	187;191,1;184	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2422	porA	1146	1146	99.74	porA.l15.c4.ctg.1	1894	127.6	0	.	p	.	0	S22G	NONSYN	64	66	AGC	429	431	GGC	151;148;148	G;G;C	141;141;142	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2422	porA	1146	1146	99.74	porA.l15.c4.ctg.1	1894	127.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	611	611	C	181	C	174	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2906	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1461	197.1	0	.	p	.	0	D41K	NONSYN	121	123	GAC	400	402	AAA	227;227;224	A;A;A	222;222;220	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2906	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1461	197.1	0	.	p	.	0	K46S	NONSYN	136	138	AAA	415	417	AGC	220;220;221	A;G;C,T	215;215;214,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2906	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1461	197.1	0	.	p	.	0	V75I	NONSYN	223	225	GTT	502	504	ATT	219;218;220	A;T;T	203;200;204	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2906	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1461	197.1	0	.	p	.	0	T87A	NONSYN	259	261	ACT	538	540	GCT	222;226;229	G;C;T	215;220;224	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2906	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1461	197.1	0	.	p	.	0	T89S	NONSYN	265	267	ACC	544	546	AGC	228;228;234	A;G;C	223;225;228	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2906	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1461	197.1	0	.	p	.	0	F131Y	NONSYN	391	393	TTT	670	672	TAT	259;258;259	T;A;T	246;245;244	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2906	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1461	197.1	0	.	p	.	0	N134E	NONSYN	400	402	AAT	679	681	GAG	250;249;251	G,T;A;G	238,1;236;239	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2906	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1461	197.1	0	.	p	.	0	V135F	NONSYN	403	405	GTG	682	684	TTT	255;255;256	T;T;T	235;241;243	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2906	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1461	197.1	0	.	p	.	0	G140K	NONSYN	418	420	GGA	697	699	AAA	254;254;255	A;A;A	242;242;243	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2906	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1461	197.1	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	706	708	CAA	259;261;262	C;A;A	246;247;249	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2906	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1461	197.1	0	.	p	.	0	Q187R	NONSYN	559	561	CAA	838	840	CGA	229;231;233	C;G;A,G	221;223;223,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2906	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1461	197.1	0	.	p	.	0	S189N	NONSYN	565	567	AGC	844	846	AAC	231;231;230	A;A;C	217;218;219	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2906	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1461	197.1	0	.	p	.	0	E212K	NONSYN	634	636	GAA	913	915	AAA	255;256;254	A;A;A	242;244;238	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2906	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1461	197.1	0	.	p	.	0	A270T	NONSYN	808	810	GCT	1087	1089	ACT	208;208;211	A;C;T	194;198;200	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2906	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1461	197.1	0	.	p	.	0	A272V	NONSYN	814	816	GCG	1093	1095	GTG	214;215;212	G;T;G,A	203;203;200,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2906	porB1b	1047	1047	97.04	porB1b.l15.c30.ctg.1	1461	197.1	1	SNP	p	G120K	0	.	.	358	360	GGC	637	639	GGC	256;256;252	G,A;G;C	240,1;242;236	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	11548	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5009	230.1	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2087	2089	CAT	246;245;247	C;A;T	240;239;241	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_F_02142c	rpsJ.WHO_F_02142c	1	1	27	1306	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1076	120.0	1	SNP	p	V57M	0	.	.	169	171	GTG	462	464	GTG	267;269;268	G;T;G	250;251;251	rpsJ.WHO_F_02142c:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
